Carole Nuechterlein

Insider Reports History

Entity
Individual
Location
C/O Avexis, Inc., 2275 Half Day Road, Suite 160, Bannockburn, IL
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Carole Nuechterlein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carole Nuechterlein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Director Common Stock 11M $8.34M $0.76 Oct 25, 2023 Indirect
Aligos Therapeutics, Inc. Director Warrant (Right to Buy) 3.97M Oct 25, 2023 Indirect
Aligos Therapeutics, Inc. Director Stock Option (Right to Buy) 60K Jun 27, 2024 Direct
Entrada Therapeutics, Inc. Director Stock Option (Right to Buy) 11.9K Jun 2, 2022 Direct

Insider Reports Filed by Carole Nuechterlein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALGS Aligos Therapeutics, Inc. Jun 27, 2024 1 $0 4 Jun 28, 2024 Director
ALGS Aligos Therapeutics, Inc. Feb 27, 2024 2 $0 4 Feb 28, 2024 Director
ALGS Aligos Therapeutics, Inc. Oct 25, 2023 2 $6.5M 4 Oct 27, 2023 Director, 10%+ Owner
ALGS Aligos Therapeutics, Inc. Jul 20, 2023 1 $0 4 Jul 21, 2023 Director
ALGS Aligos Therapeutics, Inc. Jun 23, 2022 1 $0 4 Jun 27, 2022 Director
TRDA Entrada Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 1 $0 4 Nov 1, 2021 Director
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Director
ALGS Aligos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 17, 2021 Director